Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Lu-yi Huang"'
Autor:
Feng-li Xu, Xiao-hong Wu, Chang Chen, Kai Wang, Lu-yi Huang, Jie Xia, Yi Liu, Xue-feng Shan, Ni Tang
Publikováno v:
Cell Death and Disease, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Sorafenib, a first-line drug for advanced hepatocellular carcinoma (HCC), shows a favorable anti-tumor effect while resistance is a barrier impeding patients from benefiting from it. Thus, more efforts are needed to lift this restriction. He
Externí odkaz:
https://doaj.org/article/7b3437e5953646a1ac83373473e37db0
Autor:
Chang-Long He, Lu-Yi Huang, Kai Wang, Chen-Jian Gu, Jie Hu, Gui-Ji Zhang, Wei Xu, You-Hua Xie, Ni Tang, Ai-Long Huang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Externí odkaz:
https://doaj.org/article/3aaedfec20af47c0a7d26c77d793e466
Autor:
Peng Zhou, Wen-yi Chang, De-ao Gong, Lu-yi Huang, Rui Liu, Yi Liu, Jie Xia, Kai Wang, Ni Tang, Ai-long Huang
Publikováno v:
Oncogene. 42:725-736
Aberrantly elevated O-GlcNAcylation level is commonly observed in human cancer patients, and has been proposed as a potential therapeutic target. Speckle-type POZ protein (SPOP), an important substrate adaptor of cullin3-RING ubiquitin ligase, plays
Autor:
Ailong Huang, Haijun Deng, Jie Hu, Quanxin Long, Changlong He, Guiji Zhang, Juan Chen, Qingzhu Gao, Lu-Yi Huang, Jieli Hu, Kai Wang, Ni Tang
Publikováno v:
Clinical Infectious Diseases
Background Coronavirus disease 2019 (COVID-19) is a global pandemic with no licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–s
Publikováno v:
Nanoscale. 11:2170-2178
Efficient and accurate detection of cancer cells (from normal cells) is of great importance in cancer diagnosis and prognosis. In this work, we design a new type of polymeric substrate containing nanoparticles for detecting cancers by the dissipative
Autor:
Dongmei Gou, Lei Chang, Rui Liu, Jie Xia, Ke Yao, Bohong Wang, Haijun Deng, Wanjun Zhang, Ni Tang, Kai Wang, Qingzhu Gao, Lu-Yi Huang, Xuanming Pan, Jin Xiang, Zeping Hu, Lin Tuo, Ailong Huang, Chang Chen, Li Liang
Publikováno v:
J Clin Invest
Although cancer cells are frequently faced with a nutrient- and oxygen-poor microenvironment, elevated hexosamine-biosynthesis pathway (HBP) activity and protein O-GlcNAcylation (a nutrient sensor) contribute to rapid growth of tumor and are emerging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b588c0dacb1ba1820c43a5e1f394d60
https://europepmc.org/articles/PMC8262473/
https://europepmc.org/articles/PMC8262473/
Autor:
Lu-Yi Huang, Guiji Zhang, Youhua Xie, Ni Tang, Ailong Huang, Jie Hu, Chenjian Gu, Kai Wang, Changlong He, Wei Xu
Publikováno v:
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-3 (2021)
Autor:
Kai Wang, Jie Hu, Chenjian Gu, Lu-Yi Huang, Changlong He, Guiji Zhang, Ailong Huang, Wei Xu, Youhua Xie, Ni Tang
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health issue. To screen for antiviral drugs for COVID-19 treatment, we constructed a SARS-CoV-2 spike (S) pseudovirus system
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2584684edc280b9f7f5eea16fc79352
https://doi.org/10.1101/2020.12.13.420406
https://doi.org/10.1101/2020.12.13.420406
Publikováno v:
In Phytochemistry 2008 69(1):225-233
Autor:
Guiji Zhang, Qingzhu Gao, Lu-Yi Huang, Juan Chen, Jie-Li Hu, Jie Hu, Haijun Deng, Quanxin Long, Changlong He, Kai Wang, Ailong Huang, Ni Tang
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundCoronavirus disease 2019 (COVID-19) is a global pandemic with no licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal dynamics of SARS-CoV-2-specific neutralizing antibodies (NAbs) in COVID-19 pa